Open AccessMonoclonal Antibodies: A Therapeutic Option for the Treatment of Ophthalmic Diseases of the Eye Posterior Segment
Author(s) -
Catalina Ayón,
Daniel Castán,
Adrián Mora,
Dunia Naranjo,
Francini Obando,
Juan José Mora
Publication year - 2022
Publication title -
borneo journal of pharmacy
Language(s) - English
Resource type - Journals
ISSN - 2621-4814
DOI - 10.33084/bjop.v5i3.2095
Subject(s) - medicine , infliximab , certolizumab pegol , ranibizumab , posterior segment of eyeball , adalimumab , bevacizumab , diabetic retinopathy , adverse effect , ophthalmology , monoclonal antibody , uveitis , macular degeneration , endophthalmitis , monoclonal , rheumatoid arthritis , dermatology , pathology , surgery , antibody , immunology , disease , pharmacology , chemotherapy , diabetes mellitus , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom